{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:28:51Z","timestamp":1789147731386,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014355","name":"Nirma University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014355","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004415","name":"NATO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004415","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bioorg.2024.107754","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T20:32:18Z","timestamp":1725049938000},"page":"107754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["A comprehensive review of synthetic strategies and SAR studies for the discovery of PfDHODH inhibitors as antimalarial agents. Part 2: Non-DSM compounds"],"prefix":"10.1016","volume":"153","author":[{"given":"Manmohan","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco L.","family":"Lolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek K.","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107754_b0005","unstructured":"World Health Organization 2022, n.d. https:\/\/cdn.who.int\/media\/docs\/default-source\/malaria\/world-malaria-reports\/world-malaria-report-2022.pdf?sfvrsn=40bfc53a_4 (accessed January 23, 2024)."},{"key":"10.1016\/j.bioorg.2024.107754_b0010","article-title":"A comprehensive review of synthetic strategies and SAR studies for the discovery of PfDHODH inhibitors as antimalarial agents. Part 1: triazolopyrimidine, isoxazolopyrimidine and pyrrole-based (DSM) compounds","author":"Sharma","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107754_b0015","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1080\/07391102.2020.1784288","article-title":"High-throughput virtual screening approach involving pharmacophore mapping, ADME filtering, molecular docking and MM-GBSA to identify new dual target inhibitors of Pf DHODH and Pf Cytbc1 complex to combat drug resistant malaria","volume":"39","author":"Rawat","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2024.107754_b0020","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202303982","article-title":"Biannual account of anti-malarial agents reported in 2021 and 2022: A comprehensive coverage","volume":"9","author":"Dhameliya","year":"2024","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2024.107754_b0025","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/cmdc.200600240","article-title":"Malaria chemotherapeutics Part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development","volume":"2","author":"Schlitzer","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2024.107754_b0030","series-title":"Chemical Research on Cinchonas","author":"Pelletier","year":"1820"},{"key":"10.1016\/j.bioorg.2024.107754_b0035","first-page":"482","volume":"14","year":"1945","journal-title":"Pac. Hist. Rev."},{"key":"10.1016\/j.bioorg.2024.107754_b0040","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/bph.16144","article-title":"Advances in malaria pharmacology and the online guide to Malaria Pharmacology: IUPHAR review 38","volume":"180","author":"Armstrong","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2024.107754_b0045","first-page":"45","article-title":"Drug resistance in malaria","volume":"41","author":"Farooq","year":"2004","journal-title":"J. Vector Borne Dis."},{"key":"10.1016\/j.bioorg.2024.107754_b0050","first-page":"849","article-title":"The total synthesis of quinine","volume":"66","author":"Woodward","year":"1944","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2024.107754_b0055","article-title":"Mefloquine for preventing malaria during travel to endemic areas","volume":"2017","author":"Tickell-Painter","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bioorg.2024.107754_b0060","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/014107680710011411","article-title":"A lesson learnt: the rise and fall of Lariam and Halfan","volume":"100","author":"Croft","year":"2007","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.bioorg.2024.107754_b0065","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nature04640","article-title":"Production of the antimalarial drug precursor artemisinic acid in engineered yeast","volume":"440","author":"Ro","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2024.107754_b0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/pgmj.2004.028399","article-title":"Artemisinins","volume":"81","author":"Woodrow","year":"2005","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.bioorg.2024.107754_b0075","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s12936-015-0948-0","article-title":"A randomized trial of the efficacy of artesunate and three quinine regimens in the treatment of severe malaria in children at the Ebolowa Regional Hospital, Cameroon","volume":"14","author":"Maka","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.bioorg.2024.107754_b0080","unstructured":"World Health Organization 2001, n.d. https:\/\/iris.who.int\/bitstream\/handle\/10665\/66952\/WHO_CDS_RBM_2001.35.pdf?sequence=1&isAllowed=y."},{"key":"10.1016\/j.bioorg.2024.107754_b0085","unstructured":"World Health Organization (WHO). Guidelines for the Treatment of Malaria. 3rd ed.; Available online:, (n.d.). http:\/\/www.who.int\/malaria\/publications\/atoz\/9789241549127\/en\/."},{"key":"10.1016\/j.bioorg.2024.107754_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24224095","article-title":"The development of novel compounds against malaria: quinolines, triazolpyridines, pyrazolopyridines and pyrazolopyrimidines","volume":"24","author":"Pinheiro","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107754_b0095","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2024.107754_b0100","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1473-3099(15)70046-0","article-title":"Towards real-time monitoring of artemisinin resistance","volume":"15","author":"Menard","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bioorg.2024.107754_b0105","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.2147\/DDDT.S265602","article-title":"Recent progress in the development of new antimalarial drugs with novel targets","volume":"14","author":"Belete","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bioorg.2024.107754_b0110","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.apjtm.2016.04.012","article-title":"Insights into the pyrimidine biosynthetic pathway of human malaria parasite Plasmodium falciparum as chemotherapeutic target","volume":"9","author":"Krungkrai","year":"2016","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.bioorg.2024.107754_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2022.107787","article-title":"Integrated structure-guided computational design of novel substituted quinolizin-4-ones as Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors","author":"Vyas","year":"2022","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107754_b0120","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2174\/187152610791163336","article-title":"Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy","volume":"10","author":"Phillips","year":"2010","journal-title":"Infect. Disord. - Drug Targets"},{"key":"10.1016\/j.bioorg.2024.107754_b0125","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/1062936X.2016.1189959","article-title":"Identification of novel Pf DHODH inhibitors as antimalarial agents via pharmacophore-based virtual screening followed by molecular docking and in vivo antimalarial activity","volume":"27","author":"Vyas","year":"2016","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.bioorg.2024.107754_b0130","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0969-2126(00)00530-X","article-title":"Structure of dihydroorotate dehydrogenase B","volume":"8","author":"Rowland","year":"2000","journal-title":"Structure"},{"key":"10.1016\/j.bioorg.2024.107754_b0135","series-title":"Struct. Bioinforma. Appl. Preclin. Drug Discov. Process","first-page":"177","article-title":"Structure-based drug design of PfDHODH inhibitors as antimalarial agents","author":"Bhagat","year":"2019"},{"key":"10.1016\/j.bioorg.2024.107754_b0140","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/abbi.2001.2409","article-title":"Dihydrooxonate is a substrate of dihydroorotate dehydrogenase (DHOD) providing evidence for involvement of cysteine and serine residues in base catalysis","volume":"391","author":"Bj\u00f6rnberg","year":"2001","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bioorg.2024.107754_b0145","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1021\/bi702218c","article-title":"Analysis of flavin oxidation and electron-transfer inhibition in Plasmodium falciparum dihydroorotate dehydrogenase","volume":"47","author":"Malmquist","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2024.107754_b0150","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2174\/138955711797247707","article-title":"Recent developments in the medicinal chemistry and therapeutic potential of dihydroorotate dehydrogenase (DHODH) inhibitors","volume":"11","author":"Vyas","year":"2011","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107754_b0155","doi-asserted-by":"crossref","first-page":"7236","DOI":"10.3390\/ijms22137236","article-title":"Identification of 3,4-dihydro-2H,6H-pyrimido[1,2-c][1,3]benzothiazin-6-imine derivatives as novel selective inhibitors of plasmodium falciparum dihydroorotate dehydrogenase","volume":"22","author":"Hartuti","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2024.107754_b0160","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1007\/s00044-012-0216-6","article-title":"3D QSAR studies on 5-(2-methylbenzimidazol-1-yl)-N-alkylthiophene-2-carboxamide derivatives as P. falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors","volume":"22","author":"Vyas","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2024.107754_b0165","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/13543776.2023.2280596","article-title":"Recent advances on patents of Plasmodium falciparum dihydroorotate dehydrogenase (Pf DHODH) inhibitors as antimalarial agents","volume":"33","author":"Gehlot","year":"2023","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2024.107754_b0170","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa6645","article-title":"A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria","volume":"7","author":"Phillips","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bioorg.2024.107754_b0175","unstructured":"Medicine for Malaria Venture. MMV-Supported Projects., (n.d.). https:\/\/www.mmv.org\/research-development\/mmv-supported-projects."},{"key":"10.1016\/j.bioorg.2024.107754_b0180","doi-asserted-by":"crossref","DOI":"10.4155\/fmc-2023-0113","article-title":"Medicinal chemistry approaches for the discovery of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors as antimalarial agents","author":"Vyas","year":"2023","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107754_b0185","doi-asserted-by":"crossref","first-page":"26999","DOI":"10.1074\/jbc.M109.028589","article-title":"Structural plasticity of malaria dihydroorotate dehydrogenase allows selective binding of diverse chemical scaffolds","volume":"284","author":"Deng","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107754_b0190","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.3390\/molecules24213917","article-title":"Synthesis and antiplasmodial activity of 1,2,3-triazole-naphthoquinone conjugates","volume":"24","author":"Oramas-Royo","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107754_b0195","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/1062936X.2023.2247326","article-title":"3D-QSAR-based design, synthesis and biological evaluation of 2,4-disubstituted quinoline derivatives as antimalarial agents","volume":"34","author":"Vyas","year":"2023","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.bioorg.2024.107754_b0200","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.bmc.2005.01.017","article-title":"Synthesis of brequinar analogue inhibitors of malaria parasite dihydroorotate dehydrogenase","volume":"13","author":"Boa","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107754_b0205","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1021\/jm060687j","article-title":"Design and synthesis of potent inhibitors of the malaria parasite dihydroorotate dehydrogenase","volume":"50","author":"Heikkil\u00e4","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107754_b0210","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1021\/jm800963t","article-title":"Structure-based design, synthesis, and characterization of inhibitors of human and Plasmodium falciparum dihydroorotate dehydrogenases","volume":"52","author":"Davies","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107754_b0215","doi-asserted-by":"crossref","first-page":"33054","DOI":"10.1074\/jbc.M110.162081","article-title":"Novel inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in the mouse model","volume":"285","author":"Booker","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107754_b0220","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1021\/ml200143c","article-title":"Optimization of potent inhibitors of P. falciparum dihydroorotate dehydrogenase for the treatment of malaria","volume":"2","author":"Skerlj","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107754_b0225","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1039\/c1md00118c","article-title":"N-Substituted salicylamides as selective malaria parasite dihydroorotate dehydrogenase inhibitors","volume":"2","author":"Fritzson","year":"2011","journal-title":"MedChemComm"},{"key":"10.1016\/j.bioorg.2024.107754_b0230","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00044-010-9323-4","article-title":"Molecular modeling studies, synthesis and biological evaluation of derivatives of N-phenylbenzamide as Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors","volume":"20","author":"Desai","year":"2011","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2024.107754_b0235","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.1021\/jm400938g","article-title":"Novel selective and potent inhibitors of malaria parasite dihydroorotate dehydrogenase: discovery and optimization of dihydrothiophenone derivatives","volume":"56","author":"Xu","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107754_b0240","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1021\/jm501127s","article-title":"Design, synthesis, X-ray crystallographic analysis, and biological evaluation of thiazole derivatives as potent and selective inhibitors of human dihydroorotate dehydrogenase","volume":"58","author":"Zhu","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107754_b0245","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejmech.2016.09.073","article-title":"Evaluation of 7-arylaminopyrazolo[1,5-a]pyrimidines as anti-Plasmodium falciparum, antimalarial, and Pf-dihydroorotate dehydrogenase inhibitors","volume":"126","author":"Azeredo","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107754_b0250","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1016\/j.bmcl.2017.06.052","article-title":"Interconvertible geometric isomers of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors exhibit multiple binding modes","volume":"27","author":"McConkey","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107754_b0255","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1021\/acsmedchemlett.7b00030","article-title":"Discovery of antimalarial azetidine-2-carbonitriles that inhibit P. falciparum dihydroorotate dehydrogenase","volume":"8","author":"Maetani","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107754_b0260","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature19804","article-title":"Diversity-oriented synthesis yields novel multistage antimalarial inhibitors","volume":"538","author":"Kato","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2024.107754_b0265","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3390\/molecules23061254","article-title":"Synthesis, design, and structure-activity relationship of the pyrimidone derivatives as novel selective inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase","volume":"23","author":"Xu","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107754_b0270","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejmech.2018.11.044","article-title":"Hydroxyazole scaffold-based Plasmodium falciparum dihydroorotate dehydrogenase inhibitors: Synthesis, biological evaluation and X-ray structural studies","volume":"163","author":"Pippione","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107754_b0275","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1107\/S0907444905042642","article-title":"Structure of Plasmodium falciparum dihydroorotate dehydrogenase with a bound inhibitor","volume":"62","author":"Hurt","year":"2006","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.bioorg.2024.107754_b0280","doi-asserted-by":"crossref","first-page":"33054","DOI":"10.1074\/jbc.M110.162081","article-title":"Novel inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in the mouse model*","volume":"285","author":"Booker","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107754_b0285","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1021\/jm8001026","article-title":"Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum","volume":"51","author":"Phillips","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107754_b0290","doi-asserted-by":"crossref","first-page":"17980","DOI":"10.1074\/jbc.M114.558353","article-title":"In vitro resistance selections for Plasmodium falciparum dihydroorotate dehydrogenase inhibitors give mutants with multiple point mutations in the drug-binding site and altered growth","volume":"289","author":"Ross","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107754_b0295","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0166-6851(01)00429-7","article-title":"RNA interference (RNAi) inhibits growth of Plasmodium falciparum","volume":"119","author":"McRobert","year":"2002","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.bioorg.2024.107754_b0300","doi-asserted-by":"crossref","first-page":"41827","DOI":"10.1074\/jbc.M206854200","article-title":"Malarial dihydroorotate dehydrogenase","volume":"277","author":"Baldwin","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107754_b0305","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1021\/ml400403u","article-title":"Diversity-oriented synthesis yields a new drug lead for treatment of chagas disease","volume":"5","author":"Dandapani","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107754_b0310","first-page":"4244","article-title":"Identification of a novel dihydroorotate dehydrogenase inhibitor class by high-throughput screening and its preclinical characterization as a potent antimalarial","volume":"286","author":"Gujjar","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107754_b0315","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.1211936","article-title":"Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery","volume":"334","author":"Meister","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2024.107754_b0320","first-page":"5793","article-title":"Theranostics: Precision medicine and\/or personalized diagnostics and treatment","volume":"405","author":"Pauli","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.bioorg.2024.107754_b0325","first-page":"1928","article-title":"Structure-activity relationship study of PfDHODH inhibitors and implications for the development of antimalarial drugs","volume":"59","author":"Sugioka","year":"2019","journal-title":"J. Chem. Inf. Model."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682400659X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682400659X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T02:20:19Z","timestamp":1738203619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682400659X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":65,"alternative-id":["S004520682400659X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107754","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive review of synthetic strategies and SAR studies for the discovery of PfDHODH inhibitors as antimalarial agents. Part 2: Non-DSM compounds","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107754"}}